|
|
| (70 intermediate revisions by 3 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{Glycogen storage disease}}
| |
|
| |
|
| |
|
| {{CMG}}; {{AE}} {{Anmol}} | | {{CMG}}; {{AE}} {{Anmol}} |
|
| |
|
| | | ==Tables== |
| ==Glycogen storage disease== | |
| | |
| {| class="wikitable" | | {| class="wikitable" |
| ! colspan="2" |Glycogen storage disease
| | |+ |
| !Enzyme deficiency
| | !Diagnosis |
| !Genetics | | !Lab findings |
| !Inheritence | | ! |
| !Hypoglycemia | | ! |
| !Muscle weakness | |
| !Hepatomegaly
| |
| !Cardiomegaly
| |
| !Elevated CK
| |
| |-
| |
| |Glycogen storage disease type I
| |
| |Von Gierke's disease
| |
| |Glucose-6-phosphatase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type II
| |
| |Pompe disease
| |
| |Alpha acid-glucosidase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type III
| |
| |Cori disease
| |
| |Debranching enzyme
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type IV
| |
| |Andersen's disease
| |
| |Branching enzyme
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type V
| |
| |McArdle disease
| |
| |Muscle glycogen phosphorylase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type VI
| |
| |Hers' disease
| |
| |Liver glycogen phosphorylase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type VII
| |
| |Tauri's disease
| |
| |Muscle phosphofruktokinase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" |Glycogen storage disease type IX
| |
| |Phosphorylase b kinase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" |Glycogen storage disease type X
| |
| |Phosphoglycerate mutase
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |- | | |- |
| |Glycogen storage disease type XI
| | ! |
| |Fanconi-Bickel syndrome
| | ! |
| |Glucose transporter 2
| | ! |
| |
| | ! |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |- | | |- |
| |Glycogen storage disease type XII
| |
| |Aldolase A deficiency
| |
| |Aldolase A
| |
| |
| |
| |
| |
| |
| |
| | | | | |
| | | | | |
| Line 138: |
Line 21: |
| | | | | |
| |- | | |- |
| | colspan="2" |Glycogen storage disease type XIII
| |
| |Beta-enolase
| |
| |
| |
| |
| |
| |
| |
| | | | | |
| | | | | |
| Line 148: |
Line 26: |
| | | | | |
| |- | | |- |
| | colspan="2" |Glycogen storage disease type XIV
| |
| |Phosphoglucomutase type 2
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Glycogen storage disease type 0
| |
| |Lewis' disease
| |
| |Hepatic glycogen synthase
| |
| |
| |
| |
| |
| |
| |
| | | | | |
| | | | | |
| Line 169: |
Line 31: |
| | | | | |
| |} | | |} |
| | |
| ==References== | | ==References== |
| {{reflist|2}} | | {{reflist|2}} |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Tables
References